Phage therapy holds promise in fighting against antimicrobial resistance: Dr. Kalyan Chakravarthy

Andhra Pradesh, Guntur, November 12, 2026: Dr. Kalyan Chakravarthy Koganti, sepsis and infectious diseases specialist at SHRI Hospital, Guntur addressed a symposium organised by a Chinese University in Hong Kong recently.

Phage therapy, which uses bacteriophages to selectively eliminate harmful bacteria, holds significant potential in combating antimicrobial resistance (AMR), said Dr. Kalyan Chakravarthy Koganti, sepsis and infectious diseases specialist at SHRI Hospital, Guntur.

He said this while sharing his research experience in a press release, after presenting his team's scientific findings at an international symposium jointly organised by the Chinese University of Hong Kong and reputed biomedical research journals.

Dr. Kalyan Chakravarthy said his team's research presentation on phage therapy received appreciation from participants at the symposium. Dr. Sutharsan Govindarajan, Associate Professor and phage biologist, SRM University, AP, also presented research conducted by the team.

He described the event as an enriching learning experience, particularly the discussions on the wider applications of bacteriophages in diagnostics and therapy, including cancer research. Professor Chuanbin Mao, chair of the symposium, has been researching bacteriophages for 25 years and has contributed extensively to scientific literature, he said.

Dr. Kalyan noted that bacteriophages selectively target disease-causing bacteria without harming human beings, making them promising alternatives when antibiotics fail.

His team has administered phage therapy to a few patients at its centre with encouraging results. In collaboration with SRM University and Szeged University, Hungary, the team is working to advance its availability in India.